Handling Out of Specification (OOS) and Out of Trend (OOT) is of utmost importance to the pharma sector. The pharma companies should be aware of these two terms exhaustively as they need to perform stability tests at regular intervals to find the status of the samples of raw materials, in-process materials, bulk products, and finished products.
Out of specification (OOS) is defined as a result that falls outside the predetermined specifications or established acceptance criteria set by the manufacturer and/or the laboratory. In simple terms, the result of a stability test conducted by a quality analyst (QA) should always adhere to the previously established specifications or criteria. The QC declares the result as OOS if it doesn’t comply or agree with the given test result criteria. Similarly, out of trend (OOT) is defined as a result that falls outside the trend. The QC personnel compares the result of the current test with a set of previous results to check with the ongoing trend.
The pharma company’s standard operating procedures (SOPs) will layout steps for carrying out investigation in case an OOT or OOS is traced. In the case of OOS, the quality control (QC) will directly report for any of the sample test results going out of the predetermined specifications. However, there are three methods to find OOT. The QC can find if the sample’s test result has gone Out Of Trend (OOT) by
a) finding the average of previous readings,
b) 3 sigma approach, and
c) checking the high and low range of the previous results.
The process of finding Out of Specification (OOS) and Out of Trend (OOT) through manual procedures is quite a herculean task. It involves a lot of paperwork. The test will be first conducted by a quality analyst (QA) and manually noted down. Then, the reviewer receives the test result and goes through all the steps again to suggest the next step. He may raise investigation to find the reason for OOS or OOT. Another analyst may finally receive the sample for investigation purposes. This analyst also must repeat all the steps of testing and note down everything manually. Thus, leaving a lot of scope for transcriptional errors and compliance issues.
Further, in some companies, the production team may send a batch of raw materials or finished goods for production or sale even before completing the investigation for an OOS or OOT. This can lead to serious problems when an auditor requests for all the investigation documents of OOS or OOT. They can then question the reason for taking the next step without stringently complying with the FDA regulations.
Laboratory Information Management System (LIMS) is a software that helps in overcoming all these issues following the process of automation. By using LIMS, pharma companies can automate workflows, integrate instruments, and manage samples and other associated information. LIMS helps in automating the sample testing process wherein the analyst can easily submit the test results of batch samples. Therefore, he can avoid the tedious manual result recording process. LIMS also makes it easy for the reviewer to go through the pre-validated testing processes and suggest for investigation in case of OOS or OOT. Sometimes, the analyst also gets direct intimation about OOS or OOT. Thus, helping the analyst to take the necessary steps without wasting time and effort.
CaliberLIMS is one of the best LIMS software available for pharma companies to help in the complete automation process. CaliberLIMS pre-validated modules and calculations help the pharma companies to be 21 CFR Part 11 compliant easily and efficiently.
If you are looking to automate your work process without any hassles, just click here to know more about CaliberLIMS.